Lifecore Biomedical (LFCR) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lifecore Biomedical is the larger company by market cap ($244.1 million vs $240.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFCR | VOGX |
|---|---|---|
| Share price | $6.44 | $16.16 |
| Market cap | $244.11M | $240.06M |
| 1-day change | -0.16% | -1.40% |
| YTD return | -21.27% | — |
| 1-year return | -4.45% | — |
| 5-year return | -34.35% | — |
| EPS (TTM) | $-1.27 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.98 | $38.41 |
| 52-week low | $3.63 | $12.95 |
| Distance from 52-week high | -28.29% | -57.93% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | -2.48% | +240.35% |
| Average volume | 264.01K | 187.53K |
| Shares outstanding | 37.91M | 14.86M |
| Employees | 382 | 4 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lifecore Biomedical
LFCR stock →Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Healthcare · Drug Manufacturers - Specialty & Generic · 382 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Healthcare · Biotechnology · 4 employees
LFCR vs VOGX FAQ
Which is bigger, Lifecore Biomedical or Vogenx?
Lifecore Biomedical (LFCR) is larger, with a market capitalization of $244.11M compared with $240.06M for Vogenx (VOGX).
Are Lifecore Biomedical and Vogenx in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Lifecore Biomedical and Biotechnology for Vogenx.